Literature DB >> 8086507

Isotype-specific immune response to a single hepatitis C virus core epitope defined by a human monoclonal antibody: diagnostic value and correlation to PCR.

K Siemoneit1, M da Silva Cardoso, A Wölpl, S Epple, H Wintersinger, K Koerner, B Kubanek.   

Abstract

In this study we tested the seroreactivity of 223 selected anti-HCV-reactive blood donors to the human B-cell epitope N-VYLLPR-C (C34-39) of the hepatitis C virus core antigen. The epitope was recently identified and characterized by the human monoclonal IgG antibody Ul/F10 and is located within the amino acid residues 34-39 of the aminoterminal core region. The blood donor sera were selected from anti-HCV ELISA (Ortho, 2nd generation)-reactive samples. Sixty-seven of these sera were further reactive in RIBA (Ortho, 2nd generation). According to their RIBA pattern, these samples were divided into four groups. Samples in the first group (n = 18) reacted to all four recombinant HCV antigens. The samples of the second (n = 9) and third group (n = 8) reacted to c22-3/c33c and c22-3/c100-3, respectively. Sera from group 4 (n = 32) showed a RIBA indeterminate pattern with reactivity only to c22-3. All 223 samples were analyzed for anti-C34-39 antibodies by ELISA, and the 67 RIBA-reactive samples were additionally tested for the presence of HCV RNA by RT/PCR. In groups 1 and 2, over 80% of the samples showed anti-C34-39 reactivity which was restricted to the IgG1 isotype. In contrast, in groups 3 and 4, antibodies to the epitope C34-39 were detected in less than 10% of the samples. Interestingly, the anti-C34-39 response correlates with the presence of HCV RNA; 95.5% of the samples had coincident results in all subgroups. None of the RIBA-negative sera showed a specific seroreaction to the C34-39 peptide.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8086507     DOI: 10.1007/bf01695693

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  30 in total

1.  Second-generation RIBA to confirm diagnosis of HCV infection.

Authors: 
Journal:  Lancet       Date:  1991-04-13       Impact factor: 79.321

Review 2.  Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease.

Authors:  M Houghton; A Weiner; J Han; G Kuo; Q L Choo
Journal:  Hepatology       Date:  1991-08       Impact factor: 17.425

3.  IgG subclasses in viral infections.

Authors:  F Skvaril
Journal:  Monogr Allergy       Date:  1986

4.  Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay.

Authors:  C L Van der Poel; H T Cuypers; H W Reesink; A J Weiner; S Quan; R Di Nello; J J Van Boven; I Winkel; D Mulder-Folkerts; P J Exel-Oehlers
Journal:  Lancet       Date:  1991-02-09       Impact factor: 79.321

5.  B-cell epitopes on the hepatitis C virus nucleocapsid protein determined by human monospecific antibodies.

Authors:  T Akatsuka; M Donets; L Scaglione; W M Ching; J W Shih; A M Di Bisceglie; S M Feinstone
Journal:  Hepatology       Date:  1993-09       Impact factor: 17.425

6.  Immune response to a single peptide containing an immunodominant region of hepatitis C virus core protein: the isotypes and the recognition site.

Authors:  M Sällberg; U Rudén; B Wahren; L O Magnius
Journal:  Immunol Lett       Date:  1992-06       Impact factor: 3.685

7.  A human monoclonal antibody specific for the N terminus of the hepatitis C virus nucleocapsid protein.

Authors:  A Cerino; P Boender; N La Monica; C Rosa; W Habets; M U Mondelli
Journal:  J Immunol       Date:  1993-12-15       Impact factor: 5.422

8.  Interaction of immune sera with synthetic peptides corresponding to the structural protein region of hepatitis C virus.

Authors:  W M Ching; C Wychowski; M J Beach; H Wang; C L Davies; M Carl; D W Bradley; H J Alter; S M Feinstone; J W Shih
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

9.  Detection of hepatitis C virus (HCV) RNA by PCR related to HCV antibodies in serum and liver histology in Swedish blood donors.

Authors:  Z B Yun; G Lindh; O Weiland; B Johansson; A Sönnerborg
Journal:  J Med Virol       Date:  1993-01       Impact factor: 2.327

10.  Enzyme-linked immunosorbent assay for antibodies against the capsid protein of hepatitis C virus with a synthetic oligopeptide.

Authors:  H Okamoto; E Munekata; F Tsuda; K Takahashi; S Yotsumoto; T Tanaka; K Tachibana; Y Akahane; Y Sugai; Y Miyakawa
Journal:  Jpn J Exp Med       Date:  1990-08
View more
  4 in total

1.  A Single Locus Controls Interferon Gamma-Independent Antiretroviral Neutralizing Antibody Responses.

Authors:  Melissa Kane; Felicity Deiss; Alexander Chervonsky; Tatyana V Golovkina
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

2.  Improved reactivity of hepatitis C virus core protein epitopes in a conformational antigen-presenting system.

Authors:  E Buratti; M Di Michele; P Song; C Monti-Bragadin; E A Scodeller; F E Baralle; S G Tisminetzky
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

3.  Restricted isotypic antibody reactivity to hepatitis C virus synthetic peptides in immunocompromised patients.

Authors:  M Devesa; A de Saez; G León; F Sirit; C Cosson; H Bermúdez; F Liprandi; O Noya; F H Pujol
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

4.  Comparative Immunogenicity in Rabbits of the Polypeptides Encoded by the 5' Terminus of Hepatitis C Virus RNA.

Authors:  Irina Sominskaya; Juris Jansons; Anastasija Dovbenko; Natalia Petrakova; Ilva Lieknina; Marija Mihailova; Oleg Latyshev; Olesja Eliseeva; Irina Stahovska; Inara Akopjana; Ivars Petrovskis; Maria Isaguliants
Journal:  J Immunol Res       Date:  2015-11-02       Impact factor: 4.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.